Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.

Also called NCT02936622

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 176 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02936622
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, New Zealand (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02936622. Randomized; single masking; primary purpose treatment. Start 2017-02-21 (actual); primary completion 2019-04-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
Acronym
XPEDITE
Condition
Peripheral Arterial Disease (PAD)
Intervention (Device)
Zilver® Paclitaxel-Eluting Peripheral Stent
Intervention (Device)
Zilver® Paclitaxel-Eluting Peripheral Stent with slower-dissolving polymer-free paclitaxel coating
Intervention (Device)
Zilver® Paclitaxel-Eluting Peripheral Stent with higher-dose polymer-free paclitaxel coating
Lead sponsor
Cook Group Incorporated (class: industry)

Record details

Record id
cardio:ct-nct02936622
Content hash
fa56b52772e8b916bddb1a633dd6e6d89037a233fb5347c026c7f99ecf3eabfb